Consequently, we observed enhanced IFNγ+ LCMV NP396-specific CD8+ T cells after αPD-L1 therapy compared to untreated mice, as well as increased clearance of the chronic LCMVcl13 infection, which is in line with previously published data (Supplementary Figure S1, [34]). Here, CD8A is linked to infection.